Skip to content

Blog

Challenges for Measuring Immunogenicity of AAV-based Gene Therapies

Gene therapy is a powerful form of treatment that involves introducing genetic material into cells to replace defective genes resulting in the production of an…

Read More

Cell-Based NAb Assays: What We Need to Know

Cell-Based NAb Assays So, how do we deal with NAbs when it comes to the industrial production of biotherapeutic agents? The bioanalytical community adopts a…

Read More

Cell and Gene Therapies Account for a Large Portion of the Therapeutics Market

Cell and gene therapies have gone through a growth spurt in the last decade. According to data from the Alliance for Regenerative Medicine (ARM), during…

Read More

BioAgilytix Team Q&A: Meet Chris Carlin

  Tell us a little about your background and how you came to join BioAgilytix.   My first wet lab experience was gained during my…

Read More

BioAgilytix Team Q&A: Meet Reema Davis

  Tell us a little about your background and how you came to join BioAgilytix.   I did my doctoral and postdoctoral training in Cell…

Read More

BioAgilytix Team Q&A: Meet Nikhil Soni

Tell us a little about your background and how you came to join BioAgilytix. Some of my friends at my previous job joined BAL and…

Read More

CMC Requirements for Cell and Gene Therapy for IND Applications

The U.S. Food and Drug Administration (FDA) has issued Chemistry, Manufacturing, and Control (CMC) recommendations for Investigational New Drug (IND) applications for human investigational gene…

Read More

FDA RACE for Children Act: What You Should Know

Short for Research to Accelerate Cures and Equity, the RACE Act went into effect on August 18, 2020, and significantly increased the number of required…

Read More

The Benefits of Outsourcing R&D Processes to CROs

As a leading contract research organization (CRO), BioAgilytix helps companies around the world with research and development, leveraging expertise in cell-based assays, immunogenicity, biomarkers and…

Read More

Noninvasive Liquid Biopsy Assays Integrating Tumor and Immune Biomarkers Prove to Be Promising Tools in Immuno-Oncology

Tumor tissue biopsies have been the traditional method of identifying and analyzing cancer cells. But in addition to being invasive and risky, they have many…

Read More